CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in AQST — Aquestive Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in AQST
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,274,599
+$164,811 QoQ
Shares Held
306,394
+14.6% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 184 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,705,244,386 across 43 Drug Manufacturers - Specialty & Generic names. AQST ranks #37 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,003,981 | $287,726,073 | |
| 2 | VTRS |
Viatris Inc
|
13,567,342 | $215,449,390 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
974,279 | $164,204,982 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
297,162 | $161,011,285 | |
| 5 | ALKS |
Alkermes plc.
|
2,335,117 | $122,360,130 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,553,213 | $87,444,571 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
2,453,787 | $85,072,795 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
665,457 | $73,825,799 |
All Filings in AQST
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,274,599 | 306,394 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,109,788 | 267,419 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,947,825 | 301,521 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,420,815 | 254,171 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $808,950 | 244,396 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $611,027 | 210,699 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $749,981 | 210,669 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,013,629 | 203,540 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $505,107 | 194,272 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $81,272 | 19,078 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $38,537 | 19,078 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $29,189 | 19,078 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $31,478 | 19,078 | Shares | Sole | 2023-08-10 | |
| 2021-06-30 | $296,785 | 74,757 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $898,024 | 172,697 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $968,938 | 181,110 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $879,289 | 181,110 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $261,992 | 53,908 | Shares | Sole | 2020-08-20 | |
| No filing history on record for this holder in this stock. | ||||||